TY - JOUR
T1 - Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care
T2 - A Mayo Clinic pilot
AU - Tevaarwerk, Amye J.
AU - Karam, Dhauna
AU - Gatten, Clare A.
AU - Harlos, Elizabeth S.
AU - Maurer, Matthew J.
AU - Giridhar, Karthik V.
AU - Haddad, Tufia C.
AU - Alberts, Steven R.
AU - Holton, Sara J.
AU - Stockham, Abigail
AU - Leventakos, Konstantinos
AU - Hubbard, Joleen M.
AU - Mansfield, Aaron S.
AU - Halfdanarson, Thorvardur R
AU - Chen, Ruqin
AU - Jochum, Jacob A.
AU - Schwecke, Anna S.
AU - Eiring, Rachel A.
AU - Carroll, Jamie L.
AU - Riaz, Irbaz Bin
AU - McWilliams, Robert R.
AU - Galanis, Evanthia
AU - Mandrekar, Sumithra J.
N1 - Publisher Copyright:
© 2024 American Cancer Society.
PY - 2025/1/1
Y1 - 2025/1/1
N2 - Introduction: Structured data capture requires defined languages such as minimal Common Oncology Data Elements (mCODE). This pilot assessed the feasibility of capturing 5 mCODE categories (stage, disease status, performance status (PS), intent of therapy and intent to change therapy). Methods: A tool (SmartPhrase) using existing and custom structured data elements was Built to capture 4 data categories (disease status, PS, intent of therapy and intent to change therapy) typically documented as free-text within notes. Existing functionality for stage was supported by the Build. Participant survey data, presence of data (per encounter), and time in chart were collected prior to go-live and repeat timepoints. The anticipated outcome was capture of >50% sustained over time without undue burden. Results: Pre-intervention (5-weeks before go-live), participants had 1390 encounters (1207 patients). The median percent capture across all participants was 32% for stage; no structured data was available for other categories pre-intervention. During a 6-month pilot with 14 participants across three sites, 4995 encounters (3071 patients) occurred. The median percent capture across all participants and all post-intervention months increased to 64% for stage and 81%–82% for the other data categories post-intervention. No increase in participant time in chart was noted. Participants reported that data were meaningful to capture. Conclusions: Structured data can be captured (1) in real-time, (2) sustained over time without (3) undue provider burden using note-based tools. Our system is expanding the pilot, with integration of these data into clinical decision support, practice dashboards and potential for clinical trial matching.
AB - Introduction: Structured data capture requires defined languages such as minimal Common Oncology Data Elements (mCODE). This pilot assessed the feasibility of capturing 5 mCODE categories (stage, disease status, performance status (PS), intent of therapy and intent to change therapy). Methods: A tool (SmartPhrase) using existing and custom structured data elements was Built to capture 4 data categories (disease status, PS, intent of therapy and intent to change therapy) typically documented as free-text within notes. Existing functionality for stage was supported by the Build. Participant survey data, presence of data (per encounter), and time in chart were collected prior to go-live and repeat timepoints. The anticipated outcome was capture of >50% sustained over time without undue burden. Results: Pre-intervention (5-weeks before go-live), participants had 1390 encounters (1207 patients). The median percent capture across all participants was 32% for stage; no structured data was available for other categories pre-intervention. During a 6-month pilot with 14 participants across three sites, 4995 encounters (3071 patients) occurred. The median percent capture across all participants and all post-intervention months increased to 64% for stage and 81%–82% for the other data categories post-intervention. No increase in participant time in chart was noted. Participants reported that data were meaningful to capture. Conclusions: Structured data can be captured (1) in real-time, (2) sustained over time without (3) undue provider burden using note-based tools. Our system is expanding the pilot, with integration of these data into clinical decision support, practice dashboards and potential for clinical trial matching.
KW - computerized medical record
KW - data collection, discrete data
KW - electronic health record
KW - patients with cancer
KW - structured data
UR - http://www.scopus.com/inward/record.url?scp=85191263962&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85191263962&partnerID=8YFLogxK
U2 - 10.1002/cncr.35304
DO - 10.1002/cncr.35304
M3 - Article
C2 - 38662502
AN - SCOPUS:85191263962
SN - 0008-543X
VL - 131
JO - Cancer
JF - Cancer
IS - 1
M1 - e35304
ER -